Up to £20 million is available for multidisciplinary consortia to develop and evaluate integrated diagnostic solutions for early detection and diagnosis. This includes funding from the Industrial Strategy Challenge Fund (ISCF).
The Industrial Strategy Challenge Fund (ISCF) has a programme in data to early diagnosis and precision medicine. The programme is led by Innovate UK and the Medical Research Council (MRC), part of UK Research and Innovation.
Innovate UK will invest up to £17 million in the research, development and evaluation of integrated diagnostic solutions. An additional investment of up to £3 million is available for oncology-focused projects from Cancer Research UK.
Integrated diagnostics are disruptive innovations that link technologies, data, care pathways and systems to create new diagnostic and precision medicine solutions. The aim is to detect and diagnose earlier in the disease course, more sensitively and specifically, and with more nuanced information on prognosis and/or therapy selection.
This competition aims to accelerate development of innovative diagnostic tools and technologies by multi-disciplinary and cross-sector consortia.
Your project can focus on early development of new modality combinations (such as the combination of imaging and genomic information with new algorithms) and their detection technologies, to later stage refinement of more established tools. However, even in earlier stage development you must consider how your proposed solution could be used in clinical practice and be integrated into NHS care pathways.
Your project must involve collaboration between industry and the UK’s supporting healthcare and research infrastructure. This will be critical in ensuring new products, processes and services are fit for purpose and solutions can be translated into clinical settings. Your project can include health economic studies, modelling of care pathways and the generation of evidence to support adoption.
The maximum grant your consortium can apply for is £3.5 million. The total eligible project costs for each consortium, including industry contributions and any other co-funding, must not exceed £10 million.
25 September 2019, 12pm